Article-url
/cancer/education/systemic-cancer-treatment-types
article-config
showHicBadges: true
content

When discussing cancer treatment, new terms often come up quickly, and many people find themselves listening, processing, and forming questions all at once. There are several ways to treat cancer, and having a general sense of these options can help make conversations feel more manageable and give you a clearer picture of what may come next as you move through care.

Your care team might talk to you about local treatments like surgery and radiation, or systemic treatments such as chemotherapy, targeted therapy, and immunotherapy. Local treatments target cancer in a specific part of the body, and systemic treatments work throughout the body to reach cancer cells wherever they are.

While all treatments share the same goal of treating cancer, each works in a different way, and not every option is right for every person. Your care team will consider many factors and will work closely with you to find the best option for your situation.

This overview focuses on three systemic approaches — chemotherapy, targeted therapy, and immunotherapy — with the goal of helping you understand how these treatments work and differ so you can feel more prepared to discuss options with your doctor.

content
The differences between chemotherapy, immunotherapy, and targeted therapy

Chemotherapy, targeted therapy, and immunotherapy are three common cancer treatment approaches, but they work in different ways. Each approach may be used alone, together, or at different points over time, depending on individual needs.

A simple way to understand the differences is what each approach acts on in the body:

  • Chemotherapy targets fast-growing cells throughout the body, including cancer cells. Because it does not rely on specific features of a tumor, it can be used across many cancer types and stages. It is often given in cycles over a set period and may be used alongside other treatments.
  • Immunotherapy works by influencing the body's immune system to recognize and respond to cancer, rather than acting directly on cancer cells. It can be used for a range of cancers, and in some cases the effects may continue even after treatment pauses or ends.
  • Targeted therapy focuses on specific features of cancer cells, such as genes or proteins that help them grow or survive. It is typically considered when biomarker testing shows that a tumor has features a targeted therapy can address.

Because these approaches work differently, they tend to come with different side effects, and experiences vary widely. In some cases, these treatments may be used together or at different points over time, depending on individual needs and the overall care plan.

content
What is chemotherapy?

Chemotherapy (sometimes called chemo) is a type of treatment that uses medicines, often a combination of two or more drugs, to kill or slow the growth of fast-growing cells in the body, including cancer cells.

Because chemotherapy acts on all fast-growing cells in your body, not just cancer cells, it can also affect some of your healthy cells, such as those in hair follicles, the digestive system, or even your blood. This is the reason behind some of the common side effects you may experience when having chemotherapy, such as:

  • Fatigue
  • Nausea or vomiting
  • Hair thinning or hair loss
  • Bruising
  • Anemia

Many side effects can be managed with supportive care, and not everyone will share the same experience.

Chemotherapy can be given in several different ways depending on cancer type, including:

  • Through a vein (intravenous or IV infusion) or by injections
  • By mouth, as pills or a liquid
  • Applied to the skin as a topical cream

Chemotherapy is used as treatment for cancer at all stages, but the role of chemo can differ depending on when it's used. For many early-stage solid tumors, chemotherapy may be given before surgery to help shrink a tumor and support a better surgical outcome, or after surgery to help address any remaining cancer cells. In some cancers, chemotherapy may be used as the primary treatment.

Treatment is usually delivered in cycles, with built-in rest periods to give your body time to recover. How long treatment lasts and how often you receive it will depend on the type of cancer, the specific chemotherapy medicine, and how your body responds.

Chemotherapy may be used on its own or alongside other treatments, depending on the type of cancer being treated and the treatment plan you and your healthcare provider agree on together.

content

1/3

of cancer patients undergo chemotherapy

About 1/3 of cancer patients undergo chemotherapy as a part of their cancer treatment.

content
What is immunotherapy?

Your immune system helps detect and destroy abnormal cells in your body, including cancer cells. Sometimes, though, cancer cells can avoid detection, which allows them to keep growing.

Immunotherapy is a type of cancer treatment that helps your body's own immune system fight cancer by training it to better recognize and attack cancer cells.

Immunotherapy can be given in different ways, including:

  • Through a vein (IV infusion)
  • By mouth, as a pill or capsule
  • On the skin, as a topical cream
  • Directly into the bladder (intravesical) for certain types of cancer

Treatment schedules for immunotherapy can vary depending on the type of cancer being treated, the stage of cancer, the type of immunotherapy, and how well the treatment is working. Some immunotherapy treatments may be given every few weeks in cycles, while others may be given as a one-time treatment, like CAR-T cell therapy. Your care team will work with you to determine the appropriate treatment length.

There are several types of immunotherapies. Here are a few you may hear about:

  • Checkpoint inhibitors: Immune system cells have proteins that act as "checkpoints," which help prevent them from attacking healthy cells. Some cancer cells use these checkpoints to avoid being detected. Checkpoint inhibitors block this process, allowing the immune system to recognize and attack cancer cells. This is like taking the brakes off your immune system so it can detect and destroy cancer cells more effectively.
  • CAR-T therapy: This approach starts by collecting a blood sample and separating out certain immune cells called T cells. In a lab, these cells are modified so they can better recognize cancer cells and then are multiplied before being reintroduced to your body. Once added, they help your immune system better find and fight cancer cells. CAR-T therapy is most often used to treat blood cancers.
  • Immune-stimulating therapies: This approach works by indirectly activating parts of your immune system to strengthen its response to cancer cells.

Because immunotherapy increases your immune system's activity, it can sometimes cause your immune system to affect healthy tissues or trigger broader inflammation. This can lead to side effects such as:

  • Flu-like symptoms, such as fever or fatigue
  • Heart palpitations
  • Sinus congestion
  • Nausea or vomiting
  • Diarrhea
  • Colitis
  • Cytokine release syndrome: a reaction causing widespread inflammation in the body

Experiences can vary widely, from mild to severe. Your healthcare provider will monitor side effects throughout your treatment plan and help you manage any you may be experiencing.

content
What is targeted therapy?

Targeted therapy is designed to focus on specific molecules that help cancer cells grow and survive. Each cancer has a unique combination of these molecules, including genes and proteins, known as biomarkers. By acting on specific features of cancer cells, targeted therapy is often described as a form of "precision medicine."

To guide treatment decisions, healthcare providers first need to identify whether specific biomarkers are present in your cancer. This is done through a process called "biomarker testing." Knowing which biomarkers are involved helps determine whether a targeted therapy may be effective for you and can also help guide your care team away from treatments that may be less likely to work. This can make treatment more precise and personalized.

Targeted therapies are designed to act on these biomarkers, using drugs that interact with specific features of cancer cells. These therapies can work in different ways depending on where the target is found, which may be on or inside the cancer cell. Read What are cancer biomarkers and what is biomarker testing? to learn more.

Targeted therapies generally fall into two categories:

  • Small-molecule drugs, which are often taken as an oral pill or capsule. These are small enough to get inside cells and act on targets within them.
  • Monoclonal antibodies, which are usually given through a vein by an IV infusion. They can work by marking cancer cells for the immune system to recognize and destroy, stopping cancer cells from growing, or causing them to be destroyed directly.

Targeted therapy may be taken for different lengths of time, depending on how it fits into your overall treatment plan and how well you're responding to it.

Because some healthy cells can carry the same biomarkers that targeted therapies act on, this can affect normal cells as well, which may lead to side effects.

Side effects from targeted therapy can vary depending on the individual and can range in severity. These may include:

  • Diarrhea
  • Liver-related problems
  • High blood pressure
  • Fatigue
  • Issues with blood clotting

Not everyone experiences these side effects, and your healthcare provider can help with strategies if side effects occur.

content
How healthcare providers develop treatment plans

Treatment plans are based on multiple pieces of information working together, not just one factor. This is why two people with the same type of cancer may receive different treatment recommendations.

Common factors that can shape a plan include:

  • The type of cancer and where it started
  • The stage, or extent of disease (how much and where). To learn more about this, read the What is cancer staging? article.
  • Biomarkers or tumor markers, if testing is done and relevant biomarkers are found
  • Other health conditions and medicines you take
  • The overall goals of care, which you can discuss with your team
content
While healthcare providers will guide your treatment planning, it can be helpful for you to take an active role in these conversations. Asking questions about how your plan was developed, what different options involve, and what to expect can help you make shared decisions with your care team. Open conversations help ensure both medical and personal priorities are reflected in decisions.
content
Taking the next step in your care

Chemotherapy, immunotherapy, and targeted therapy are often discussed together, but they work in different ways. They may be used on their own, combined, or used at different points over time depending on your treatment plan.

Understanding how these approaches differ can help you follow your care plan and feel more prepared for conversations about your treatment options.

As you prepare for your next appointment, consider writing down symptoms, listing medications, and bringing a few questions about what your team is recommending and why. The Prepare for care page can help you get organized so you can discuss what matters to you and leave the visit feeling more informed.

content

Frequently
asked questions

card

Is chemotherapy radiation?

No. Chemotherapy and radiation therapy are different types of cancer treatment. Chemotherapy uses medicines that kill cancer cells or slow their growth, while radiation therapy uses high doses of radiation to kill cancer cells and shrink tumors.

card

Can I receive more than one type of treatment at the same time (for example, chemo plus immunotherapy)?

Yes, people can receive more than one type of treatment during their care. For example, chemotherapy, targeted therapy, or immunotherapy may be used alongside surgery or radiation, or at different stages of treatment. The approach depends on individual needs and how your cancer responds over time.

card

What should I ask my oncologist if I'm not sure which treatment type is best for me?

Asking clear, open-ended questions can help you better understand your options and take part in treatment decisions. You might consider asking:

  • How does my cancer type, stage, or test results affect which treatments are being considered?
  • What is each treatment designed to do?
  • How is the treatment given, and how long might it last?
  • What side effects could occur, and how are they usually managed?
  • How might this treatment fit with my daily life and personal priorities?
  • Are there other options that could be considered now or later?
card

Can my treatment plan change over time if my cancer stops responding to one type of therapy?

Yes, treatment plans can change over time. If a cancer stops responding to one particular type of therapy, your care team may reassess the situation and discuss other options that could be considered. This might involve adjusting the current treatment, trying a different type of therapy, or using treatments in a new sequence or combination. In some cases, biomarker testing may be recommended to help guide next steps, especially if new treatment decisions need to be made. Learn more about the Importance of biomarker testing.

card

How do I speak with my healthcare provider about getting biomarker testing?

You can start by asking whether biomarker testing is recommended for your type of cancer and how the results could affect your treatment plan, such as informing the use of targeted therapy or immunotherapy. It may also help to ask what biomarker testing would involve, for example, whether testing would be done on tumor tissue, blood, or another sample. Read How to talk to your doctor about biomarker testing for more information.

card

If my cancer doesn't have the 'right' biomarkers, what treatment options might still be available?

Not having an actionable biomarker does not mean there are no treatment options available. Biomarker results are still useful because they can help your care team understand which treatments may be less likely to help, and focus on other appropriate options instead. Depending on your cancer type, those options may still include chemotherapy and other treatments. Read The importance of biomarker testing for more information.

card

What markers in blood indicate cancer?

There is no single blood marker or biomarker that always means someone has cancer. Some tumor markers can be measured in blood and may provide helpful information, but not every cancer has a known blood biomarker. Biomarker testing results are usually interpreted alongside other tests, such as biopsies or imaging, rather than being used on their own to confirm a diagnosis.

card

How long does biomarker testing take?

The timing can vary depending on the type of test, the sample being used, whether extra processing or specialist testing is needed, and practical factors such as whether enough tumor tissue is available. Some advanced molecular tests that are sent to specialist laboratories can take as long as 2 to 3 weeks to come back, so it can be helpful to ask your care team when results are expected. Read How biomarker testing works for more information.

eyebrow
Build your knowledge
question
Targeted therapy can usually be initiated without biomarker testing.
correct_answer
True
correct_icon
correct_heading
Not quite
correct_body
Correct answer: Targeted therapy is often considered when biomarker testing shows that a tumor has characteristics that the treatment can address. Most of the time, a tumor needs to be tested to see if it contains targets for which there is a therapy.
incorrect_answer
False
incorrect_icon
incorrect_heading
That's correct!
incorrect_body
Targeted therapy is often considered when biomarker testing shows that a tumor has characteristics that the treatment can address. Most of the time, a tumor needs to be tested to see if it contains targets for which there is a therapy.
content

Cancer resources and guidance

Discover information to help you understand cancer and talk to your doctor.

article-urls
  • /cancer/education/importance-of-biomarker-testing
  • /cancer/education/cancer-clinical-trials
  • /cancer/education/talk-to-your-doctor-about-biomarker-testing
  • /cancer/education/how-biomarker-testing-works
article-config
showHicBadges: true
content
References

American Cancer Society. CAR T-cell therapy and its side effects. American Cancer Society website. Revised July 7, 2025. Accessed May 6, 2026. https://www.cancer.org/cancer/managing-cancer/treatment-types/immunotherapy/car-t-cell.html.

American Cancer Society. Chemotherapy side effects. American Cancer Society website. Revised May 15, 2025. Accessed May 6, 2026. https://www.cancer.org/cancer/managing-cancer/treatment-types/chemotherapy/chemotherapy-side-effects.html

American Cancer Society. Immunotherapy. American Cancer Society website. Revised August 7, 2025. Accessed May 6, 2026. https://www.cancer.org/cancer/managing-cancer/treatment-types/immunotherapy.html

American Cancer Society. Targeted therapy side effects. American Cancer Society website. Revised June 2, 2025. Accessed July 13, 2026. https://www.cancer.org/cancer/managing-cancer/treatment-types/targeted-therapy/side-effects.html

American Cancer Society. Understanding your options for cancer treatment. American Cancer Society website. Revised July 24, 2025. Accessed May 6, 2026. https://www.cancer.org/cancer/managing-cancer/making-treatment-decisions/making-decisions.html

American Cancer Society. Waiting for your biopsy or cytology test results. American Cancer Society website. Revised March 24, 2026. Accessed May 6, 2026. https://www.cancer.org/cancer/diagnosis-staging/tests/biopsy-and-cytology-tests/waiting-for-your-biopsy-or-cytology-test-results.html

American Cancer Society. What if cancer treatments stop working? American Cancer Society website. Revised July 31, 2025. Accessed May 6, 2026. https://www.cancer.org/cancer/managing-cancer/making-treatment-decisions/if-cancer-treatments-stop-working.html

Anand U, Dey A, Singh Chandel AK, et al. Cancer chemotherapy and beyond: current status, drug candidates, associated risks and progress in targeted therapeutics. Genes Dis. 2023;10(4):1367‑1401. doi:10.1016/j.gendis.2022.02.007

Cancer Research Institute. The difference between cancer immunotherapy and chemotherapy. Cancer Research Institute website. April 6, 2025. Accessed May 6, 2026. https://www.cancerresearch.org/blog/difference-cancer-immunotherapy-and-chemotherapy

Centers for Disease Control and Prevention. Cancer treatments and survivorship. August 26, 2024. Accessed May 6, 2026. https://www.cdc.gov/cancer-survivors/patients/treatments.html

Centers for Disease Control and Prevention. Information for Patients Who Are Getting Chemotherapy. August 25, 2025. Accessed May 6, 2026. https://www.cdc.gov/cancer-preventing-infections/patients/index.html

Hoque F. Shared decision making in patient care: advantages, barriers and potential solutions. J Brown Hosp Med. 2024;3(4):13‑15. doi:10.56305/001c.122787

Janczewski LM, Cotler J, Merkow RP, et al. Alterations in Cancer Treatment During the First Year of the COVID-19 Pandemic in the US. JAMA Netw Open. 2023;6(10):e2340148. doi:10.1001/jamanetworkopen.2023.40148

Mayo Clinic. Cancer treatment. July 26, 2024. Accessed May 6, 2026. https://www.mayoclinic.org/tests-procedures/cancer-treatment/about/pac-20393344

Montori VM, Ruissen MM, Hargraves IG, et al. Shared decision making as a method of care. BMJ Evid Based Med. 2023;28(4):213‑217. doi:10.1136/bmjebm-2022-112068

National Cancer Institute. Biomarker testing for cancer treatment. December 14, 2021. Accessed May 6, 2026. https://www.cancer.gov/about-cancer/treatment/types/biomarker-testing-cancer-treatment

National Cancer Institute. How cancer is diagnosed. January 17, 2023. Accessed May 6, 2026. https://www.cancer.gov/about-cancer/diagnosis-staging/diagnosis

National Cancer Institute. CAR T cells: engineering patients’ immune cells to treat their cancers. February 26, 2025. Accessed May 6, 2026. https://www.cancer.gov/about-cancer/treatment/research/car-t-cells

National Cancer Institute. Chemotherapy to treat cancer. May 15, 2025. Accessed May 6, 2026. https://www.cancer.gov/about-cancer/treatment/types/chemotherapy

National Cancer Institute. Immune checkpoint inhibitors. April 7, 2022. Accessed May 6, 2026. https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/checkpoint-inhibitors

National Cancer Institute. Immune system modulators. September 24, 2019. Accessed May 6, 2026. https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/immune-system-modulators

National Cancer Institute. Immunotherapy to treat cancer. September 24, 2019. Accessed May 6, 2026. https://www.cancer.gov/about-cancer/treatment/types/immunotherapy

National Cancer Institute. Immunotherapy side effects. February 16, 2023. Accessed May 6, 2026. https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/side-effects

National Cancer Institute. T‑cell transfer therapy. August 5, 2024. Accessed May 6, 2026. https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/t-cell-transfer-therapy

National Cancer Institute. Targeted therapy to treat cancer. May 31, 2022. Accessed May 6, 2026. https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies

Tilak TVSVGK, Patel A, Kapoor A. Molecular basis and clinical application of targeted therapy in oncology. Med J Armed Forces India. 2023;79(2):128‑135. doi:10.1016/j.mjafi.2023.02.001

Wilkinson AM. Immunotherapy. Can Fam Physician. 2021;67(7):512‑515. doi:10.46747/cfp.6707512